MRI awarded $31M NIH contract to provide chemistry support for National Toxicology Program

In nearly 40 years of continuous support to the National Toxicology Program (NTP), MRI has studied more than 2,000 chemicals and prepared in excess of 5,000 reports on chemicals in everyday use for which there had been limited toxicological data

Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences.  Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.  

Typically, chemicals selected by NTP for study are chosen because of the high concern for public or occupational health or because of their close structural relationship to chemicals known to have toxic effects at a high exposure index.  Chemicals tested for toxicity can include ingredients in foods, personal care products, prescription drugs, nutritional supplements, household cleaners, and lawn care products.  

The contract is a continuation of work provided by MRI for the NIH's NTP since 1972 and includes studies such as: 2Year Bio-assay, Short-Term Toxicology, Developmental Toxicology, Reproductive Toxicology, and High Throughput Screening Initiative for Predictive Toxicology. During that time, MRI has issued more than 5,000 technical reports on almost 2,000 different study chemicals and processed almost 3,000 High Throughput Screening chemicals.

"We are proud to that NIH has selected MRI to continue our chemistry support for NTP toxicology research programs.  Not only is the NTP one of our longest running continuous programs, with the first NTP contract dating back to the early 1970s, we are honored to provide such an important service to the public," said MRI Senior Vice President and Director of Research Operations Thomas M. Sack, Ph.D.  

SOURCE Midwest Research Institute

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool maps millions of CD8+ T cells to advance disease research